Reach Us +44-1647-403003
Cerebral Venous Sinus Thrombosis In Heterozygous Prothrombin G20210A Mutation In Egyptian Child With An Excellent Outcome | 43683
ISSN: 2165-7920

Journal of Clinical Case Reports
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Cerebral venous sinus thrombosis in heterozygous prothrombin G20210A mutation in Egyptian child with an excellent outcome

3rd Global Experts Meeting on Medical Case Reports

Tarek Hamed Attia

Zagazig University, Egypt

ScientificTracks Abstracts: J Clin Case Rep

DOI: 10.4172/2165-7920.C1.005

Prothrombin gene G20210A mutation is a risk factor for the development of deep vein thrombosis. We present a 6 year old Egyptian boy who had vomiting associated with headache and dizziness. His conscious level was normal with neither focal neurological signs nor papilledema. Brain computed tomographic scan, magnetic resonance imaging and magnetic resonance venography (MRV) revealed thrombosis of the superior sagittal and left transverse sinuses. The patient was heterozygous for prothrombin gene G20210A mutation. He has received enoxaparin and warfarin. Brain imaging follow-up, after 1 month, showed complete resolution of the thrombus. The child was followed up for 1 year and he was very healthy. Cerebral venous thrombosis must be considered in the differential diagnosis of any neurological symptoms, even mild symptoms and prothrombin gene G20210A mutation must be considered in the screening of Egyptian children. Early diagnosis and treatment can be a good prognostic index.

Tarek Hamed Attia has completed his MBBCh, Masters in Pediatrics and MD in Pediatrics from Zagazig University School of Medicine, Egypt. He is currently a Professor of Pediatrics, Zagazig University, Egypt. He is a Member in Research Board Pediatrics and Hematology and he has many publications in Pediatrics and Hematology. He is also a Chairman for Postgraduate Education and Examination Board in Pediatric Department, Zagazig University. He has published many papers in reputed journals and has been serving as an Editorial Board Member of reputed journals. He has attended many international conferences as speaker and as chairperson.

Email: [email protected]

Relevant Topics